Trials / Completed
CompletedNCT04829903
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin: Results From a Randomized Double Blinded Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 116 (actual)
- Sponsor
- Corporacion Parc Tauli · Academic / Other
- Sex
- All
- Age
- 12 Years – 19 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin
Detailed description
To observe the efficacy, effect on glycemic control, impact on BMI and incidence of adverse effects of Dulaglutide and to compare it to Liraglutide in individuals aged thirteen to eighteen who have Type 2 diabetes mellitus and are obese.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dulaglutide | Dulaglutide injections |
| DRUG | Liraglutide | Liraglutide injections |
Timeline
- Start date
- 2020-01-02
- Primary completion
- 2021-03-29
- Completion
- 2021-11-20
- First posted
- 2021-04-02
- Last updated
- 2022-03-14
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04829903. Inclusion in this directory is not an endorsement.